Rain Oncology Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rain Oncology Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2022.
  • Rain Oncology Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $1.23M, a 31.8% increase year-over-year.
  • Rain Oncology Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $4.9M, a 0.7% increase year-over-year.
  • Rain Oncology Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.86M, a 57% increase from 2021.
  • Rain Oncology Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.09M, a 257% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $4.86M +$1.76M +57% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 $3.09M +$2.23M +257% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $865K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.